• 1
    Crowther MA, Ginsberg JS, Hirsh J. Practical aspects of anticoagulant therapy. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, eds. Hemostasis and Thrombosis. Basic Principles & Clinical Practice 4th edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2000: 1498516.
  • 2
    von Känel R. Psychosocial stress and cardiovascular disease – current opinion. Swiss Med Wkly 2012; 142: w13502.
  • 3
    Austin AW, Patterson SM, von Känel R. Hemoconcentration and hemostasis during acute stress: interacting and independent effects. Ann Behav Med 2011; 42: 15373.
  • 4
    Hjemdahl P, von Känel R. Haemostatic effects of stress. In: Hjemdahl P, Rosengren A, Steptoe A, eds. Stress and Cardiovascular Disease. London: Springer, 2012: pp. 89110.
  • 5
    Blombäck M, Konkle BA, Manco-Johnson MJ, Bremme K, Hellgren M, Kaaja R. ISTH SSC subcommittee on women’s health issues preanalytical conditions that affect coagulation testing, including hormonal status and therapy. J Thromb Haemost 2007; 5: 8558.
  • 6
    Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. American college of chest physicians. Pharmacology and management of the vitamin K antagonists: American college of chest physicians evidence-based clinical practice guidelines (8th Edition). Chest 2008; 133 (Suppl. 6) : 160S98S.
  • 7
    De Boer D, Ring C, Wood M, Ford C, Jessney N, McIntyre D, Carroll D. Time course and mechanisms of mental stress-induced changes and their recovery: hematocrit, colloid osmotic pressure, whole blood viscosity, coagulation times, and hemodynamic activity. Psychophysiology 2007; 44: 63949.
  • 8
    von Känel R, Kudielka BM, Haeberli A, Stutz M, Fischer JE, Patterson SM. Prothrombotic changes with acute psychological stress: combined effect of hemoconcentration and genuine coagulation activation. Thromb Res 2009; 123: 62230.
  • 9
    Austin AW, Wirtz PH, Patterson SM, Stutz M, von Känel R. Stress-induced alterations in coagulation: assessment of a new hemoconcentration correction technique. Psychosom Med 2012; 74: 28895.
  • 10
    Frimerman A, Miller HI, Laniado S, Keren G. Changes in hemostatic function at times of cyclic variation in occupational stress. Am J Cardiol 1997; 79: 725.
  • 11
    Hawk TL, Havrda DE. Effect of stress on international normalized ratio during warfarin therapy. Ann Pharmacother 2002; 36: 61720.
  • 12
    Black PH. The inflammatory response is an integral part of the stress response: implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X. Brain Behav Immun 2003; 17: 35064.
  • 13
    Lukas PS, Neugebauer A, Schnyder S, Demarmels Biasiutti F, Krummenacher R, Gander Ferrari ML, von Känel R. Depressive symptoms, perceived social support, and prothrombotic measures in patients with venous thromboembolism. Thromb Res 2012; doi: 10.1016/j.thromres.2012.04.011.
  • 14
    Herrmann C, Buss U, Snaith RP. HADS-D Hospital Anxiety and Depression Scale Deutsche Version: ein Fragebogen zur Erfassung von Angst und Depressivität in der somatischen Medizin. Bern: Huber Verlag, 1995.
  • 15
    Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 36170.
  • 16
    Stöber J. Besorgnis: ein vergleich dreier inventare zur erfassung allgemeiner Sorgen. Zschr Diff Diagn Psychol 1995; 16: 5063.
  • 17
    Stöber J, Bittencourt J. Weekly assessment of worry: an adaptation of the Penn state worry questionnaire for monitoring changes during treatment. Behav Res Ther 1998; 36: 64556.
  • 18
    Bullinger M, Heinisch M, Ludwig M, Geier S. Skalen zur erfassung des wohlbefindens psychometrische überprüfung des Profile of Mood States (POMS). Zschr Diff Diagn Psychol 1990; 11: 5361.
  • 19
    McNair DM, Lorr M, Doppelman LE. Profile of Mood States Instrument. San Diego, CA: Educational and Testing Service, 1971.
  • 20
    Mittag O, Maurischat C. A comparison of the Cook-Medley Hostility Scale (Ho scale) and the content scales ‘cynicism’, ‘anger’, and ‘type A’ out of the MMPI-2: on the future assessment of hostility. Z Med Psychol 2004; 13: 712.
  • 21
    Hathaway SR, McKinley JC, Engel RR. MMPI-2. Manual. Bern: Huber Verlag, 2000.
  • 22
    Zürcher M, Sulzer I, Barizzi G, Lämmle B, Alberio L. Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature. Thromb Haemost 2008; 99: 41626.
  • 23
    Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990; 1: 2328.
  • 24
    Platt AB, Localio AR, Brensinger CM, Cruess DG, Christie JD, Gross R, Parker CS, Price M, Metlay JP, Cohen A, Newcomb CW, Strom BL, Laskin MS, Kimmel SE. Risk factors for nonadherence to warfarin: results from the IN-RANGE study. Pharmacoepidemiol Drug Saf 2008; 17: 85360.
  • 25
    von Känel R, Kudielka BM, Hanebuth D, Preckel D, Fischer JE. Different contribution of interleukin-6 and cortisol activity to total plasma fibrin concentration and to acute mental stress-induced fibrin formation. Clin Sci 2005; 109: 617.
  • 26
    Papoulis A. Probability and Statistics. New York: Prentence-Hall International Editions, 1990.
  • 27
    von Känel R, Mills PJ, Fainman C, Dimsdale JE. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease? Psychosom Med 2001; 63: 53144.
  • 28
    Strike PC, Steptoe A. Psychosocial factors in the development of coronary artery disease. Prog Cardiovasc Dis 2004; 46: 33747.
  • 29
    Rosengren A, Fredén M, Hansson PO, Wilhelmsen L, Wedel H, Eriksson H. Psychosocial factors and venous thromboembolism: a long-term follow-up study of Swedish men. J Thromb Haemost 2008; 6: 55864.
  • 30
    Enga KF, Brækkan SK, Hansen-Krone IJ, Hansen JB. Emotional states and future risk of venous thromboembolism. The Tromsø Study. Thromb Haemost 2012; 107: 48593.
  • 31
    Watanabe H, Kodama M, Tanabe N, Nakamura Y, Nagai T, Sato M, Okabe M, Aizawa Y. Impact of earthquakes on risk for pulmonary embolism. Int J Cardiol 2008; 129: 1524.
  • 32
    DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 21017.
  • 33
    Kneeland PP, Fang MC. Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism. Patient Prefer Adherence 2010; 4: 5160.
  • 34
    Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9: 4656.
  • 35
    Goldman-Mellor S, Brydon L, Steptoe A. Psychological distress and circulating inflammatory markers in healthy young adults. Psychol Med 2010; 40: 207987.
  • 36
    Levi M, van der Poll T. Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med 2005; 15: 2549.
  • 37
    Coyne JC, van Sonderen E. No further research needed: abandoning the Hospital and Anxiety Depression Scale (HADS). J Psychosom Res 2012; 72: 1734.